These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28729695)

  • 1. The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation.
    Yoshida M; Watanabe T; Narita Y; Sato Y; Goshima F; Kimura H; Murata T
    Sci Rep; 2017 Jul; 7(1):6044. PubMed ID: 28729695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.
    Masud HMAA; Watanabe T; Yoshida M; Sato Y; Goshima F; Kimura H; Murata T
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBI2 expression in B lymphocytes is controlled by the Epstein-Barr virus transcription factor, BRRF1 (Na), during viral infection.
    Cornaby C; Jafek JL; Birrell C; Mayhew V; Syndergaard L; Mella J; Cheney W; Poole BD
    J Gen Virol; 2017 Mar; 98(3):435-446. PubMed ID: 27902324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
    Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
    Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T; Fujita M; Kudoh A
    Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Epstein-Barr virus BGLF3.5 gene and two upstream open reading frames in lytic viral replication in HEK293 cells.
    Watanabe T; Fuse K; Takano T; Narita Y; Goshima F; Kimura H; Murata T
    Virology; 2015 Sep; 483():44-53. PubMed ID: 25965794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.
    Liu X; Cohen JI
    J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the TSG101 gene in Epstein-Barr virus late gene transcription.
    Chua HH; Lee HH; Chang SS; Lu CC; Yeh TH; Hsu TY; Cheng TH; Cheng JT; Chen MR; Tsai CH
    J Virol; 2007 Mar; 81(5):2459-71. PubMed ID: 17182691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encyclopedia of EBV-Encoded Lytic Genes: An Update.
    Murata T
    Adv Exp Med Biol; 2018; 1045():395-412. PubMed ID: 29896677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the epstein-barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1.
    Segouffin-Cariou C; Farjot G; Sergeant A; Gruffat H
    J Gen Virol; 2000 Jul; 81(Pt 7):1791-9. PubMed ID: 10859385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.
    Saito S; Murata T; Kanda T; Isomura H; Narita Y; Sugimoto A; Kawashima D; Tsurumi T
    J Virol; 2013 Apr; 87(7):4060-70. PubMed ID: 23365429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
    Dyson OF; Pagano JS; Whitehurst CB
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells.
    Liu SF; Wang H; Lin XC; Xiang H; Deng XY; Li W; Tang M; Cao Y
    Cell Biol Int; 2008 Aug; 32(8):1006-13. PubMed ID: 18579417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Epstein-Barr virus and cellular gene expression during the early phases of Epstein-Barr virus lytic induction.
    Auburn H; Zuckerman M; Smith M
    J Med Microbiol; 2016 Nov; 65(11):1243-1252. PubMed ID: 27625030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus Lytic Cycle Reactivation.
    McKenzie J; El-Guindy A
    Curr Top Microbiol Immunol; 2015; 391():237-61. PubMed ID: 26428377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase.
    Murata T; Isomura H; Yamashita Y; Toyama S; Sato Y; Nakayama S; Kudoh A; Iwahori S; Kanda T; Tsurumi T
    Virology; 2009 Jun; 389(1-2):75-81. PubMed ID: 19427010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.